Skip to main content

Rothblatt Martine A's Form 4 filing

United Therapeutics Corp (UTHR) · filed Apr 29, 2024

Accession no.
0001415889-24-011662
Filed
Apr 29, 2024
Trade date
Apr 25-26, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 9 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.69M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rothblatt Martine ACIK 0001106578Director, Officer (CHAIRPERSON & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 25, 2024Common StockMOption exerciseAcquired+3,600$129.49+$466,1643,730Direct
Apr 25, 2024Common StockSSaleDisposed−2,056$235.02F2−$483,201.121,674Direct
Apr 25, 2024Common StockSSaleDisposed−1,203$236.04F3−$283,956.12471Direct
Apr 25, 2024Common StockSSaleDisposed−341$236.84F4−$80,762.44130Direct
Apr 26, 2024Common StockMOption exerciseAcquired+3,600$129.49+$466,1643,730Direct
Apr 26, 2024Common StockSSaleDisposed−835$234.36F5−$195,690.62,895Direct
Apr 26, 2024Common StockSSaleDisposed−2,271$235.23F6−$534,207.33624Direct
Apr 26, 2024Common StockSSaleDisposed−417$236.34F7−$98,553.78207Direct
Apr 26, 2024Common StockSSaleDisposed−77$237.00−$18,249130Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 25, 2024Common StockMOption exerciseDisposed−3,600$0.00$0299,069Direct
Apr 26, 2024Common StockMOption exerciseDisposed−3,600$0.00$0295,469Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $234.495 to $235.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $235.525 to $236.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $236.615 to $237.045. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $233.79 to $234.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $234.80 to $235.795. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $235.81 to $236.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)